Investigating the Impact of Phenolic and Terpene Fractions extracted from <i>Prunus arabica</i> on p53 Protein Expression in AMJ13 and SK-GT-4 Human Cancer Cell Lines


  • Matin A. Mahmood Department of Pharmacology, College of Medicine, Al-Nahrain University, Kadhimiya, Baghdad, Iraq
  • Abdulkareem H. Abd Department of Pharmacology, College of Medicine, Al-Nahrain University, Kadhimiya, Baghdad, Iraq
  • Enas J. Kadhim Department of Pharmacognosy and Medicinal Plants, College of Pharmacy, University of Baghdad, Baghdad, Iraq


esophagus cancer, breast cancer, terpene fraction, phenolic fraction, Tumor protein, Prunus arabica


Breast cancer is the most frequently diagnosed cancer in women, accounting for a quarter of all cases. The burden of cancer in transitional countries is rising. An esophageal cancer diagnosis typically carries a poor prognosis, as well as a high incidence and mortality rate. Apoptosis, angiogenesis, and tumorigenesis are all controlled by the tumor suppressor protein p53. In clinical oncology, many researchers revealed promising effective phytotherapy methods for cancer patients, compared to antitumor xenobiotics. Study objectives were to study the mechanism of cytotoxicity of the phenolic fraction from <i>Prunus arabica</i> on breast cancer (AMJ13) and Oesophagus adenocarcinoma cancer (SK-GT-4) cell lines by measuring human tumor protein (p53) expression. Cells were treated with the half maximal inhibitory concentration (IC50) concentrations for each compound, then cells were collected with trypsinization and centrifuged. Cell precipitate was lysed using lysis buffer. The supernatant protein concentration was determined by Bicinchoninic Acid (BCA) procedure, finally p53 expression assayed using an Enzyme-Linked Immunosorbent Assay kit (ELISA). Phenolic fraction showed a significance increase in p53 protein expression on both AMJ13 and SK-GT-4 cancer cell lines (p value <0.05) while terpene fraction did not show any significance in both cell lines in comparison to untreated control group (p value<0.05). Phenolic fractions augment p53 expression giving a mechanistic insight into the fraction's cytotoxic attributes. Consequently, the terpene fraction serves as a potent anticancer agent through an alternate mechanism. The findings of this study offer a novel understanding of the biological functions of the phenolic fraction in relation to cancer therapy.

Author Biography

Matin A. Mahmood, Department of Pharmacology, College of Medicine, Al-Nahrain University, Kadhimiya, Baghdad, Iraq

Department of Pharmacology, College of Pharmacy, Al-Kitab University, Altun-Kopre, Kirkuk, Iraq


Lopes CM, Dourado A, Oliveira R. Phytotherapy and Nutritional Supplements on Breast Cancer. Biomed Res Int.; 2017:7207983.

Huang FL, Yu SJ. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg. 2018;41(3):210-15.

Fang P, Zhou J, Liang Z, Yang Y, Luan S, Xiao X, Li X, Zhang H, Shang Q, Zeng X, Yuan Y. Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications. Front Immunol. 2022; 13:975986.

Koual M, Tomkiewicz C, Cano-Sancho G, Antignac JP, Bats AS, Coumoul X. Environmental chemicals, breast cancer progression and drug resistance. Environ Health. 2020;19(1):117.

Abu-raghif, A. R., Jasim, G. A., & Hanoon, M. M. Anti-proliferative activity of zizyphus spina christi leaves methanol extract against rhabdomyosarcoma (rd) cell line. International Journal of Pharmacy and Pharmaceutical Sciences, 2017;9(2): 279-282.

Oubaid, E. N., Abu-Raghif, A. R., & Al-Sudani, I. M. Phytochemical Screening and Antioxidant Activity of Uncaria tomentosa Extract: In Vitro and In Vivo Studies. Medical Journal of Babylon, 2023;20(1):136-42.

Ahmed S, Nawaz S, Murtey MD, Ibrahim M, Ahmad W, Idrees MA, Che Jalil NA, Othman NH. Evaluation of Effect of Honey Sugars Analogue Therapy against Breast Cancer Induced by 1-Methyl-1-nitrosourea in In Vivo Breast Cancer Model. J Oncol. 2022:6457266.

Yilmaz M, Kalkan M, Demirbağ H. Seed characteristics of Amygdalus arabica in Adıyaman region of turkey. Dendrobiology. 2020;84:49–57.

Kitic D, Miladinovic B, Randjelovic M, Szopa A, Sharifi-Rad J, Calina D, Seidel V. Anticancer Potential and Other Pharmacological Properties of Prunus armeniaca L.: An Updated Overview. Plants. 2022;11(14):1885

Marvalim C, Datta A, Lee SC. Role of p53 in breast cancer progression: An insight into p53 targeted therapy. Theranostics. 2023;13(4):1421-42.

Ungerleider NA, Rao SG, Shahbandi A, Yee D, Niu T, Frey WD, Jackson JG. Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment. Breast Cancer Res. 2018;20(1):115.

Melling N, Norrenbrock S, Kluth M, Simon R, Hube-Magg C, Steurer S, Hinsch A, Burandt E, Jacobsen F, Wilczak W, Quaas A, Bockhorn M, Grupp K, Tachezy M, Izbicki J, Sauter G, Gebauer F. p53 overexpression is a prognosticator of poor outcome in esophageal cancer. Oncol Lett. 2019;17(4):3826-34.

Mahmood MA, Abd AH and Kadhim EJ. Assessing the cytotoxicity of phenolic and terpene fractions extracted from Iraqi Prunus arabica on AMJ13 and SK-GT-4 human cancer cell lines. F1000Res. 2023,12:433.

Al-Shammari AM, Alshami MA, Umran MA, Almukhtar AA, Yaseen NY, Raad K, Hussien AA. Establishment and characterization of a receptor-negative, hormone-nonresponsive breast cancer cell line from an Iraqi patient. Breast Cancer (Dove Med Press). 2015;7:223-30.

Contino G, Eldridge MD, Secrier M, Bower L, Fels Elliott R, Weaver J, Lynch AG, Edwards PA, Fitzgerald RC. Whole-genome sequencing of nine esophageal adenocarcinoma cell lines. F1000Res. 2016;5:1336.

Wang Y, Kong B, Chen X, Liu R, Zhao Y, Gu Z, Jiang Q. BMSC exosome-enriched acellular fish scale scaffolds promote bone regeneration. J Nanobiotechnology. 2022;20(1):444.

Liu C, Wang JL, Wu DZ, Yuan YW, Xin L. Methionine restriction enhances the chemotherapeutic sensitivity of colorectal cancer stem cells by miR-320d/c-Myc axis. Mol Cell Biochem. 2022;477(7):2001-13.

Zhang S, Li Y, Li T, Zhang Y, Li H, Cheng Z, Peng N, Liu Y, Xu J, He H. Activable Targeted Protein Degradation Platform Based on Light-triggered Singlet Oxygen. J Med Chem. 2022;65(4):3632-43.

Oren M. p53: not just a tumor suppressor. J Mol Cell Biol. 2019;11(7):539-43.

Vakili SA, George A, Ayatollahi SA, Martorell M, Ostrander EA, Salehi B, Martins N, Sharifi-Rad J. Phenolic compounds, saponins and alkaloids on cancer progression: emphasis on p53 expression and telomere length. Cell Mol Biol (Noisy-le-grand). 2020;66(4):110-19.

Hwerif, N., Raghif, A., & Kadhim, E. Effect of terpenes fraction of Iraqi cicer arietinum in experimentally induced hyperlipidemic mice. International Journal of Health Sciences, 2022; 6(S5), 10514–30.

Muhseen ZT, Li G. Promising Terpenes as Natural Antagonists of Cancer: An In-Silico Approach. Molecules. 2019;25(1):155.

Nazir S, El-Sherif AA, Abdel-Ghani NT, Ibrahim MAA, Hegazy MF, Atia MAM. Lepidium sativum Secondary Metabolites (Essential Oils): In Vitro and In Silico Studies on Human Hepatocellular Carcinoma Cell Lines. Plants (Basel). 2021;10(9):1863.



How to Cite

Mahmood, M. A., Abd, A. H., & Kadhim, E. J. (2023). Investigating the Impact of Phenolic and Terpene Fractions extracted from <i>Prunus arabica</i> on p53 Protein Expression in AMJ13 and SK-GT-4 Human Cancer Cell Lines: Tropical Journal of Natural Product Research (TJNPR), 7(11), 5266–5269. Retrieved from